Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 37 citing articles:

Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits
Ahmad Karami, Sajad Fakhri, Leila Kooshki, et al.
Molecules (2022) Vol. 27, Iss. 19, pp. 6474-6474
Open Access | Times Cited: 73
Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome
Xiaonan Zhang, Zeping Wang, Xiaoya Li, et al.
Journal of Ethnopharmacology (2023) Vol. 309, pp. 116304-116304
Closed Access | Times Cited: 26
Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition
Sha Chen, Kenneth Overberg, Zakiya Ghouse, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116477-116477
Open Access | Times Cited: 9
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Vincenzo Quagliariello, Maria Laura Canale, Isabella Bisceglia, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 8
Preparation, characterization, and anticancer evaluation of polydatin conjugated with zinc MOF and encapsulated by liponiosomes as a potential nanotool-induce apoptosis
Hanan M. Alharbi, Zienab E. Eldin, Mohamed Taha, et al.
Journal of Molecular Structure (2024) Vol. 1315, pp. 138982-138982
Closed Access | Times Cited: 6
In Vitro and In Vivo Cardioprotective Effects of Curcumin against Doxorubicin-Induced Cardiotoxicity: A Systematic Review
Qian Zhang, Lei Wu
Journal of Oncology (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 27
Polydatin Inhibits Hepatocellular Carcinoma Cell Proliferation and Sensitizes Doxorubicin and Cisplatin through Targeting Cell Mitotic Machinery
Umar Farooq, Hao Wang, Jingru Hu, et al.
Cells (2023) Vol. 12, Iss. 2, pp. 222-222
Open Access | Times Cited: 14
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1487-1487
Open Access | Times Cited: 5
Exploring the Relationship between G-Quadruplex Nucleic Acids and Plants: From Plant G-Quadruplex Function to Phytochemical G4 Ligands with Pharmaceutic Potential
Andrea Patrizia Falanga, Monica Terracciano, Giorgia Oliviero, et al.
Pharmaceutics (2022) Vol. 14, Iss. 11, pp. 2377-2377
Open Access | Times Cited: 19
Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Polydatin could Ameliorate Type 2 Diabetes Mellitus-induced Nonalcoholic Fatty Liver by Suppressing Nuclear Factor Kappa-light-chain-enhancer of Activated B Cells/Nucleotide-binding Domain, Leucine-rich Repeat-containing Receptor, Pyrin Domain-containing 3 Inflammasome Axis Activation
Jinli Luo, Ling Zhou, Jinghan Xu, et al.
World Journal of Traditional Chinese Medicine (2025)
Open Access
Understanding the Mechanisms of Chemotherapy-Related Cardiotoxicity Employing hiPSC-Derived Cardiomyocyte Models for Drug Screening and the Identification of Genetic and Epigenetic Variants
A Solomon, Swarna Dabral, R. G. Brajesh, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 9, pp. 3966-3966
Open Access
NLRP3-mediated inflammation in cardio-oncology: sterile yet harmful
Adolfo G Mauro, Eleonora Mezzaroma, Stefano Toldo, et al.
Translational research (2022) Vol. 252, pp. 9-20
Open Access | Times Cited: 18
Polydatin ameliorates hepatic ischemia-reperfusion injury by modulating macrophage polarization
Haili Bao, Chuan-Zhi Chen, Changzhen Ren, et al.
Hepatobiliary & pancreatic diseases international (2022) Vol. 23, Iss. 1, pp. 25-34
Closed Access | Times Cited: 16
The Effects of Spirulina Supplementation on Cardiometabolic Risk Factors: A Narrative Review
Sara Sokary, Hiba Bawadi, Zain Zaki Zakaria, et al.
Journal of Dietary Supplements (2024) Vol. 21, Iss. 4, pp. 527-542
Open Access | Times Cited: 3
Mechanism of Astragalus membranaceus (Huangqi, HQ) for treatment of heart failure based on network pharmacology and molecular docking
Qiuxiang Chen, Juan Wang, Lihua Sun, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 10
Open Access | Times Cited: 3
Multimodal modulation of hepatic ischemia/reperfusion-induced injury by phytochemical agents: A mechanistic evaluation of hepatoprotective potential and safety profiles
Deiaa E Elsayed Abouzed, Hend A A Ezelarab, Heba Mohammed Refat M. Selim, et al.
International Immunopharmacology (2024) Vol. 138, pp. 112445-112445
Closed Access | Times Cited: 3
Polydatin prevents lipotoxicity-induced dysfunction in pancreatic β-cells by inhibiting endoplasmic reticulum stress and excessive autophagy
Wenqi Jin, Fan Meiling, Yuxin Zhang, et al.
Phytomedicine (2022) Vol. 106, pp. 154410-154410
Closed Access | Times Cited: 15
Combination of Spirulina platensis, Ganoderma lucidum and Moringa oleifera Improves Cardiac Functions and Reduces Pro-Inflammatory Biomarkers in Preclinical Models of Short-Term Doxorubicin-Mediated Cardiotoxicity: New Frontiers in Cardioncology?
Vincenzo Quagliariello, Manuela Giovanna Basilicata, Giacomo Pepe, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 12, pp. 423-423
Open Access | Times Cited: 15
Better Medications Adherence Lowers Cardiovascular Events, Stroke, and All-Cause Mortality Risk: A Dose-Response Meta-Analysis
Mengying Liu, Guowei Zheng, Xiting Cao, et al.
Journal of Cardiovascular Development and Disease (2021) Vol. 8, Iss. 11, pp. 146-146
Open Access | Times Cited: 18
Exploring the Parallel G-Quadruplex Nucleic Acid World: A Spectroscopic and Computational Investigation on the Binding of the c-myc Oncogene NHE III1 Region by the Phytochemical Polydatin
Francesca Greco, Domenica Musumeci, Nicola Borbone, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2997-2997
Open Access | Times Cited: 13
Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells
Yilin Xiong, Yan Wang, Tao Yang, et al.
American Journal of Cardiovascular Drugs (2023) Vol. 23, Iss. 5, pp. 497-518
Closed Access | Times Cited: 7
Impact of route-dependent phase-II gut metabolism and enterohepatic circulation on the bioavailability and systemic disposition of resveratrol in rats and humans: A comprehensive whole body physiologically-based pharmacokinetic modeling
Dong‐Gyun Han, Seong‐Wook Seo, Eugene Choi, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 151, pp. 113141-113141
Open Access | Times Cited: 12
Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer
Siyuan Wu, Qi Zhao, Shengjuan Liu, et al.
International Journal of Oncology (2024) Vol. 65, Iss. 2
Open Access | Times Cited: 2
Pharmacovigilance analysis of cardiac risks associated with Bruton tyrosine kinase inhibitors
Yinghong Zhai, Fangyuan Hu, Wentao Shi, et al.
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 9, pp. 857-869
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top